Rebalix
Amundi · sheet of 10 September 2026
Amundi · sheet of 10 September 2026ETF sheet · official issuer and register data
Amundi Core US Treasury Bond UCITS ETF Acc
PRAS · LU2089239193 · class UCITS ETF Acc · USD · domicile Luxembourg
Bonds · Government · Broad (all maturities) · North AmericaSFDR art. 6
Index tracked: Bloomberg U.S. Treasury Index
- TER
- 0.05%+ trans. 0.02%
- Fund size
- 13 m EUR
- Tracking difference
- −0.03%3-year avg
- 🇮🇹 tax rate
- 12.58%white list 99.40%
- Replication
- Physical
- Income
- Accumulating
- Duration
- 5.77 yrsmedium (3–7 years)
Launch 15 Jan 2020 · costs from the KID as of 2 Sept 2026 · 298 securities held · 8 venues (ESMA register)
The fund’s objective — in the issuer’s words
From the Key Information Document (KID) · 4 Aug 2026
This Sub-Fund is passively managed. The objective of this Sub-Fund is to track the performance of Bloomberg U.S Treasury Index, and to minimize the tracking error between the net asset value of the Sub-Fund and the performance of the Index. The anticipated level of the tracking error, under normal market conditions, is indicated in the prospectus of the Sub-Fund. The Index is a Total Return Index : the coupons paid by the index constituents are included in the index return. The Bloomberg U.S Treasury Index measures US dollar-denominated, fixed-rate,…
Performance since series start (in euro) — base 100
21 Jan 2020 → 8 Sept 2026 · dividends reinvested where declared by the issuer · converted at ECB rates
Returns in euro
| 1 year | +0.9% |
| 3 years | +1.8% |
| 5 years | −1.6% |
| 10 years | series too young |
| Since series start | −3.0% |
Risk · 1 / 3 / 5 years
| Volatility (ann.) | 3.36% | 4.68% | 5.51% |
| Max drawdown | −2.91% | −4.83% | −16.20% |
| Sharpe | -0.67 | 0.06 | -0.56 |
| Sortino | -0.92 | 0.09 | -0.79 |
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · PRAS · LU20892391931
RebalixPRAS · LU2089239193 · sheet of 10 September 2026
Tracking difference — year by year
Fund minus index, complete calendar years · from issuer-declared series
| Year | Fund | Index | TD |
|---|---|---|---|
| 2025 | +6.08% | +6.18% | −0.10% |
| 2024 | +0.72% | +0.75% | −0.03% |
| 2023 | +3.96% | +3.91% | +0.05% |
| 2022 | −12.35% | −12.37% | +0.01% |
| 2021 | −2.14% | −2.30% | +0.15% |
Fixed income — as declared by the issuer
Factsheet · 30 Jun 2026 · investment-grade share (BBB−/Baa3 and above): 99.6%
Rating breakdown (% of fund)
Maturity breakdown (% of fund)
Holdings
Portfolio as declared by the issuer · 1 Sept 2026 · 298 securities · top-10 weight = 8.1%
Countries (% of fund)
Sectors (% of fund)
Listing venues
ESMA register (FIRDS) and official exchange lists
PRAS · Börse Düsseldorf, Börse Frankfurt, Börse Hamburg, Börse Hannover, Börse München / gettex, Börse Stuttgart, Tradegate Exchange, Xetra (Deutsche Börse)
+ 18 unmapped venues (MTF, RFQ, professional)
Official documents
Clickable links in the PDF
The live sheet, always up to date
rebalix.com/en/etf/LU2089239193
Series, distributions, holdings and documents refresh daily.
rebalix.com/en/etf/LU2089239193
Series, distributions, holdings and documents refresh daily.
Sheet produced on 10 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.
Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.
Rebalix · PRAS · LU20892391932